Quercetin Allergy Meta-analysis: What the Evidence Says

Quick Answer

Quercetin Allergy Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 systematic review, 1 narrative review.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Although both the innate and adaptive immune systems have important roles in maintaining homeostasis with the environment, allergies result from a similar interaction of genetic factors and environmental factors, at the phenotypic level, leading to immunological dysregulation at the molecular and cellular levels (;). [Lv Zeyi (2025); evidence level 1]
• Di Lorenzo et al., 2017 Lambrecht and Hammad, 2015 Akdis, 2012 Pawankar, 2014 Warren et al., 2021 Pathogenesis of allergic diseases is considered to involve types I-IV hypersensitivity mechanisms classified by Gell and Coombs, which are often associated with coexisting multiple reaction types. [Lv Zeyi (2025); evidence level 1]
• Although age-standardized prevalence rates have slightly declined over the past three decades, the absolute number of cases has continued to rise, particularly in regions with high socio-demographic indices, partly due to population growth and increased awareness. [Zafrilla Pilar (2025); evidence level 3]
• Allergic disorders can produce a wide spectrum of clinical manifestations, ranging from mild skin or gastrointestinal symptoms to life-threatening anaphylaxis, and are often associated with comorbidities and reduced quality of life. [Zafrilla Pilar (2025); evidence level 3]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For quercetin allergy meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Lv Zeyi (2025). Quercetin exhibits multi-target anti-allergic effects in animal models: a systematic review and meta-analysis of preclinical studies. DOI: 10.3389/fphar.2025.1673712. PMCID: PMC12676024. PMID: 41357894. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12676024/
• Zafrilla Pilar (2025). Dietary Bioactive Compounds and Their Role in Allergy Prevention: A Comprehensive Review. DOI: 10.3390/nu17223506. PMCID: PMC12655493. PMID: 41305557. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12655493/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.